Setterwalls has advised LIDDS AB on the deal. LIDDS AB announced a rights issue of approximately SEK 48.6 million. LIDDS is a Swedish drug delivery company...
LIDDS AB’s SEK 48.6 Million Rights Issue
Lidds AB’s SEK 45 Million Capital Raise
Delphi has advised Lidds AB on the deal. The Board of Directors of LIDDS AB has resolved on a directed new issue of 4,314,475 shares by payment...
Lidds AB’s Research and Development Agreement With Johnson & Johnson
Setterwalls assisted the research company LIDDS AB. LIDDS AB announced that an agreement has been signed with Johnson & Johnson Enterprise Innovation Inc. to develop an oncology...